CD274 and neoplasm: This model is heterogeneously responsive to anti-PD-L1 immunotherapy and even systematically treated, genetically matched mice can demonstrate intrinsic resistance, acquired resistance, or complete response, classified on the basis of the tumor growth curves (Fig. 4E).